BTB Therapeutics, Inc.
PrivateLast Round
Seed Round
Nov 14, 2025
Est. Valuation
$6.42M
Total Funding Raised
$11.96M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BTB Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Escondido, California. Its latest recorded funding round was an Early Funding round in November 2025.
BTB Therapeutics, Inc. is a drug discovery company developing non-opioid analgesics and RNA-modifying compounds to treat rare genetic diseases and enhance cancer immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BTB Therapeutics, Inc. Comparables
Compare BTB Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neumentum, Inc. | 86% | |
| Allay Therapeutics | 84% | |
| Concentric Analgesics | 83% |
For institutional investors. Book with your work email.
BTB Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Nov 14, 2025 | ||||
| Early Funding | Nov 1, 2025 | ||||
| Seed | Feb 5, 2025 | ||||
| Convertible Debt | Jun 24, 2024 | ||||
| Convertible Debt | Oct 27, 2023 | ||||
VC Round | Apr 4, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BTB Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kyoto University Innovation Capital | Early Funding, Convertible Debt, Seed |
| SMBC Venture Capital | Early Funding, Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 14, 2025
Raised $9M in Seed funding.
- Nov 1, 2025
$7M raised in early funding.
For institutional investors. Book with your work email.
BTB Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BTB Therapeutics, Inc.'s valuation, stock price, and market status.
Is BTB Therapeutics, Inc. a public or private company?
BTB Therapeutics, Inc. is a private company.
What is the current stock price of BTB Therapeutics, Inc.?
BTB Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks BTB Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BTB Therapeutics, Inc. worth (valuation)?
BTB Therapeutics, Inc.'s valuation is estimated at $6.4M based on funding round data.
Can I buy BTB Therapeutics, Inc. stock?
BTB Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BTB Therapeutics, Inc.'s last funding round?
BTB Therapeutics, Inc.'s most recent funding round was Seed Round on November 14, 2025.
Who are the main investors in BTB Therapeutics, Inc.?
Key investors in BTB Therapeutics, Inc. include Kyoto University Innovation Capital, SMBC Venture Capital.
Will BTB Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for BTB Therapeutics, Inc..
How can I track BTB Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in BTB Therapeutics, Inc.'s shares on secondary markets.